Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside
- PMID: 6467142
- DOI: 10.1002/1097-0142(19840915)54:6<991::aid-cncr2820540608>3.0.co;2-r
Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside
Abstract
A patient with malignant histiocytosis who relapsed after receiving an Adriamycin (doxorubicin)-containing combination and radiation therapy subsequently had a complete remission on VP-16-213 and cytosine arabinoside. She remains free of disease 32 months after achieving a complete remission. VP-16-213 and cytosine arabinoside (Ara-C) deserve further evaluation in the treatment of this neoplasm.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical